ArticleFrontiers in immunology2022

A novel medication decision gene signature predicts response to individualized therapy and prognosis outcomes in hepatocellular carcinoma patients.

Jingsheng Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.